RecruitingNot Applicable

Prospective Cohort Study of Intracerebral Hemorrhage

China856 participantsStarted 2020-12-29

Plain-language summary

The investigators design a prospective, observational cohort study to provide contemporary information on the prevalence, characteristics, risk stratification，cost-effective ,treatments and prognosis of Chinese hospitalised adult patients with intracerebral hemorrhage.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Exclusion criteria

✕. patients of secondary intracerebral hemorrhage，such as hemorrhagic transformation of ischemic stroke, aneurysmal, cavernomas, arterio- venous malformations, central venous thrombosis, trauma-related, or tumor.
✕. isolated intraventricular hemorrhage or subarachnoid hemorrhage pregnant patients；
✕. surgical evacuation of hematoma；
✕. unavailability to get complete blood cell samples and presenting contraindications or refusal to MRI
✕. patients cannot be followed up for any reasons.
✕. patients death in 24 hours
✕. pregnant patients

What they're measuring

proportion of patients with a 3-month modified Rankin Scale (mRS) score≤ 3

Timeframe: 2-3years

Trial details

NCT IDNCT04707105

SponsorSecond Affiliated Hospital, School of Medicine, Zhejiang University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2025-12

Contact for this trial

Feng Gao, MD,PhD

13588451471 2202012@zju.edu.cn

View on ClinicalTrials.gov More Intracerebral Hemorrhage trials